Abstract: The ubiquitin-26S proteasome degradation system (UPS) plays a pivotal role in almost all aspects of plant life, including defending against pathogens. Although the proteasome is important for plant immunity, it has been found to be also exploited by pathogens using effectors to increase their virulence. Recent work on the XopJ effector and syringolin A/syrbactins has highlighted host proteasome inhibition as a virulence strategy of pathogens. This review will focus on these recent developments. 
Exploitation of the UPS by pathogens
Not only is the UPS involved in many aspects of plant immunity, but a variety of plant and animal pathogens subvert the host UPS for their own good [11] . To see how, it may be helpful to shortly summarize the major paradigms of plant defense against pathogens. As worked out mainly in the model plant Arabidopsis thaliana, plants have evolved a two-branched innate immune system to combat pathogens [12] . One branch is named pattern-triggered immunity (PTI) and involves a plethora of physiological and cellular defense responses adverse to pathogens, conferring basal resistance. PTI is launched after recognition of pathogens (or microbe)-associated molecular patterns (PAMPs or MAMPs) by membrane-bound pattern recognition receptors (PRRs), which exhibit structural similarity to the Toll-like innate immune receptors in mammals and insects [13, 14] . Bacterial pathogens are able to suppress PTI by using their type III secretion system (T3SS) to inject effector proteins (T3Es) into the cytoplasm of host plant cells where they block PTI-associated signaling at many points, thus resulting in effector-triggered susceptibility (ETS) [15, 16] . However, plants have evolved a second branch of innate immunity dubbed effector-triggered immunity (ETI), in which specific effectors are recognized by cognate resistance (R) proteins. This usually results in a hypersensitive reaction (HR), a form of local programmed cell death conferring nearly complete but race-specific resistance [17] . In many plants, local HR induces systemic acquired resistance against a broad spectrum of pathogens in remote tissues [18] . T3Es are known to interfere with all these defense reactions at various points [15, 16] .
Analyses of several plant-pathogen interaction systems have identified a number of T3Es that require the host proteasome for their defense-suppressing activities, thus subverting it for their own use [11] . A well-studied example is HopAB2 (alias AvrPtoB) produced by the tomato pathogen Pseudomonas syringae pv. tomato (Pst) DC3000 and some other strains that exhibits E3 ligase activity and targets host defense proteins such as PRRs for proteasomal destruction [19- [33, 34] . Exploitation of the host proteasome for the enhancement of virulence may be quite widespread not only in pathogenic bacteria, but also in other pathogens such as the oomycete Phytophthora infestans which produces the RXLR motif-containing effector AVR3. AVR3 is translocated into the cytoplasm of host cells where it stabilizes the E3 ligase CMPG1, thereby suppressing CMPG1-dependent cell death triggered by pathogen recognition [35, 36 ] .
The examples briefly discussed above show that exploitation of the host proteasome function is employed by a wide variety of pathogens to enhance their virulence. In contrast, inhibition of the host proteasome has only recently been recognized as a virulence strategy of certain pathogens. The rest of the review focuses on this recent development and covers important new research, extending a recent review with a similar topic [37] .
Proteasome inhibition as a virulence strategy of plant pathogens

A T3E with proteasome inhibiting activity
An intriguing case of proteasome inhibition to enhance virulence has recently been reported by Üstün and colleagues [38] , who identified the first T3E effector that suppresses proteasome activity. The X. campestris T3E XopJ was shown to interact with the RPT6 (regulatory particle ATPase 6) subunit of the 19S RP in yeast and in planta and to inhibit the proteasome. XopJ belongs to the YopJ T3E family of cysteine proteases/acyltransferases that is widely distributed in plant and animal pathogens as well as in plant symbionts and exhibits a characteristic catalytic triad [39] . Mutation of the catalytic triad as well as of the N-terminal myristoylation motif in XopJ abolished its proteasome-inhibiting ability, suggesting that enzymatic activity and membrane anchoring are required for proteasome inhibition.
Comparisons of wild-type and mutant strains revealed that XopJ delayed host tissue degeneration and suppressed the accumulation of normal levels of SA and SA-dependent defense responses. It is presently not clear how this works mechanistically in view of the necessary localization of XopJ at the membrane. Future research will without doubt elucidate whether proteasome inhibition is the mode of action also of other members of the YopJ superfamily of T3Es. The study of Üstün and co-workers will likely also stimulate the search for T3E-type proteasome inhibitors outside the YopJ family of proteins in other pathogens.
Syringolin A, a small-molecule proteasome inhibitor and virulence factor
Many potent small-molecule proteasome inhibitors belonging to different structural classes have been isolated from microbes and other organisms such as sponges and bryozoans (in which they probably are produced by symbiotic bacteria). While they draw intense attention as potential drug leads in the fight against certain cancer types [40] , the function of these compounds for the biology of their producers remains in most cases completely unexplored.
An exception is syringolin A (SylA), which is discussed below.
SylA was found to be secreted by strains of P. syringae pv. syringae (Pss). SylA is a tripeptide derivative consisting of an N-terminal valine and the two non-proteinogenic amino acids 3,4-dehydrolysine and 5-methyl-4-amino-2-hexenoic acid which form a twelvemembered macrolactam ring. The N-terminal valine is joined head-to-head to another valine residue via an unusual ureido group ( Figure 1 ). SylA is the major variant of a family of related compounds in which the valine residues can be substituted by isoleucine and/or the 3,4-dehydrolysine may be replaced by lysine [37, [41] [42] [43] . SylA was shown to covalently attach to the catalytic N-terminal Thr residue of all catalytic subunits of the proteasome by a Michael-type 1,4-addition to the double bond at C4 in the 12-membered macrolactam ring, thereby irreversibly inhibiting catalytic activity [44] . Proteasome inhibition is probably specific because cysteine proteases and trypsin were not inhibited. Although all three catalytic activities of the proteasome are inhibited in vitro, the β5 subunit with its ChTL activity is most sensitive, while the β1 subunit conferring CL activity is least sensitive to inhibition by SylA [44] . Similar results were obtained in living plant cells by proteasome activity imaging and profiling experiments, in which SylA seemed to target preferentially proteasomes in the nucleus [45] . As recently elucidated in A. thaliana, SylA is efficiently taken up into plant cells by YELLOW STRIPE LIKE7 (YSL7) and YSL8 transporters [46] , which belong to a plantspecific oligopeptide transporter subfamily thought to be involved in transport and distribution of metal-nicotianamine complexes [47] . SylA is the founding member of a new structural class of proteasome inhibitors dubbed syrbactins, which is characterized by the 12-membered macrolactam ring and its functional α,β-unsaturated carbonyl group [48, 49] .
Spray-inoculation experiments with the SylA-producing wild-type strain Pss B728a and a SylA-negative mutant on their bean (Phaseolus vulgaris) host revealed the mutant to cause only about 30% of brown spot disease symptoms as compared to the wild type, identifying SylA as a virulence factor [44] . Further experiments revealed that SylA not only counteracted stomatal immunity (i.e. the pathogen-induced closure of the stomata, a PTI response dependent on the SA defense pathway and its key regulator NPR1 [50] [51] [52] ) in bean and Arabidopsis, but also inhibited other SA-dependent defense reactions such as PR gene induction [52] . Inhibition of the SA defense pathway by SylA is most likely due to inhibition of the proteasome-mediated turnover of the key regulator NPR1, which is necessary for its proper functioning as mentioned above. Furthermore, wound inoculation experiments with SylA-producing Pss strains on Nicotiana benthamiana recently revealed that SylA-mediated suppression of the SA defense pathway also helps the bacteria to escape local wound sites and to colonize adjacent regions along the vascular tissue because acquired resistance was impaired [53] .
Occurrence of SylA synthetase genes in P. syringae strains
The SylA synthetase, a modular mixed non-ribosomal peptide synthetase/polyketide synthase (NRPS/PKS; see Box 1) is encoded by a gene cluster containing the five genes sylA, sylB, sylC, sylD, and sylE, the last three forming an operon [54, 55] (Figure 2A ). Sequence and architecture of these genes implied a SylA biosynthesis model also experimentally supported in most of its aspects [54] [55] [56] [57] [58] (Figure 2B ). Importantly, the structure of SylA with its 12-membered macrolactam ring containing the functional α,β-unsaturated carbonyl group is reflected in the unique architecture of the sylD gene. This allows the identification in genome data bases of homologous genes likely encoding structurally similar proteasome inhibitors in other taxa.
A recent genomics analysis of 19 diverse strains belonging to the P. syringae species complex revealed complete syl gene clusters with very high sequence conservation at conserved positions in the genomes of five of six strains belonging to group (subclade) 2, but not in strains belonging to groups 1 and 3, suggesting that SylA biosynthesis may be restricted to group 2 strains (Figure 3 ) [59] . Interestingly, group 2 strains seem to encode fewer T3Es (9 to 16) than strains of the other groups. The comparatively low numbers of T3Es encoded in the analyzed group 2 strains, which correlates with the presence genes for the biosynthesis of the phytotoxins syringopeptin and syringomycin as well as of syringolin, suggests a virulence strategy distinct from the one of group 1 (which encompasses Pst DC3000) and group 3 strains [59] .
Conflicting action of virulence factors?
Concomitant production of proteasome inhibitors with virulence factors requiring the host proteasome for their activity seems contradictory. In X. campestris pv. vesicatoria, the T3Es XopJ (proteasome inhibitor) and XopL (an E3 ligase) represent such a pair. The seeming conflict might be mitigated by spacial and/or temporal separation of production or activities [38] . In P. syringae, SylA production would seem to counteract host proteasome-requiring T3Es like HopAB2 and HopM1 or other virulence factors such as the JA-mimicking small molecule coronatine (COR). To our knowledge, COR synthetase genes or COR biosynthesis so far have not been found in strains carrying SylA synthetase genes [59, 60] . A homolog of HopAB2 (HopAB1, alias AvrPtoB B728a ) occurs in the SylA-producing strain Pss B728a, which, however, has recently been shown to be defect in its E3 ligase activity [61] . In the case of HopM1, a variant of which occurs in Pss B728a as well as in most P. syringae strains, it is also not clear whether it has a proteasome-dependent function related to the one of HopM1 DC3000 . HopM1 variants are phylogenetically and functionally diverse as evidenced by the fact that a variant from P. syringae pv. morspunorum did not complement a hopM1 DC3000 deletion mutant [59] . As mentioned above, if the potential to produce conflicting virulence factors does occur in the same strain, conflict might be resolved by differential regulation of biosynthesis during host colonization.
Syrbactins in animal pathogens
The determination of SylA's structure revealed its similarity to the glidobactins (similar to cepafungins), a family of agents from soil bacteria with anti-tumor and antifungal activity isolated more than twenty years ago [62, 63] . Like SylA, glidobactin A (GlbA) contains a 12-membered macrolactam ring with its characteristic α,β-unsaturated carbonyl group (Figure 1 ).
GlbA was shown to inhibit the ChTL and TL activities of the eukaryotic proteasome by the same mechanism as SylA, whereas the CL activity was not inhibited at all [44] . The GlbA synthetase gene cluster (glbA-glbH) was cloned from the soil bacterium K481-B101, which belongs to the Burkholderiales [64] . Sequence and architecture of glbC and glbF, which, like their homologs sylD and sylC in Pss, encode a mixed NRPS/PKS synthetase, allowed to postulate a GlbA biosynthesis model which is analogous to the one for SylA and is experimentally supported. [64, 65] (Figure 4 ).
Whereas disrupted nonfunctional glb-like gene clusters are present in strains of
Burkholderia mallei (causing glanders in donkeys and horses), apparently intact glb-like gene clusters were found in the genome sequences of the human pathogens Burkholderia pseudomallei (the causing agent of melioidosis, β-proteobacteria), Burkholderia oklahomensis (β-proteobacteria), and Photorhabdus asymbiotica (γ-proteobacteria), In addition, an intact glb-like gene cluster is also present in the insect pathogen and nematode symbiont Photorhabdus luminescens. This suggests that these pathogens have the potential to synthesize syrbactins ( Figure 5 ) [64] . Indeed, transfer of the glb-like gene cluster of Ph. luminescens ssp. laumondii TT01 into Pseudomonas putida resulted in GlbA production in the latter species [66] . Furthermore, GlbA as well as a variant named cepafungin I, the strongest proteasome inhibitor known to date, were isolated from Ph. luminescens cultures [67] . Similarly, GlbA and derivatives named luminmycins have been isolated from Ph. asymbiotica cultures and from crickets after infection with the pathogen [68] . Thus, these pathogens indeed produce syrbactin-type proteasome inhibitors, although future research must elucidate whether and how they are involved in virulence.
Evolution of syrbactins
Syrbactin synthetase-encoding genes so far have been found in a small but diverse group of plant and animal pathogens, suggesting that they were acquired by horizontal gene transfer.
Comparison of sequence and architecture of the genes encoding the NRPS/PKS synthetase modules within syl and glb gene clusters reveals that the location of the starter module genes sylC and glbF is not conserved (Figure 2 and 3) . In addition, and in contrast to sylD, whose closest homologs found in genome databases are the glbC-like genes, the closest homologs of the sylC gene are not the glbF-like genes. This suggests that sylD and glbC are descendants of a common ancestral gene, whereas sylC and glbF were independently recruited into the SylA and GlbA-like synthetase gene clusters, respectively. The starter modules not only activate different amino acids, but also catalyze the addition of tails with chemically different characters [56, 65] : in the case of SylA it is an ureido-valine, leading to a hydrophilic compound, whereas in GlbA it is a fatty acid, rendering the compound much more hydrophobic (Figure 1) . This difference determines whether and how syrbactins are taken up into cells. GlbA has antifungal activity [62] and evidently must be taken up by fungal cells such as yeast, whereas yeast is completely insensitive to SylA [46] . However, yeast can be rendered sensitive towards SylA by expression of the A. thaliana YLS7 and YSL8 plantspecific transporters [46] . Thus the different tails may be viewed as adaptations to kingdomspecific import mechanisms.
Concluding remarks
Whereas an increasing number of T3Es in both plant and animal pathogens have been found to require the host UPS for their mode of action, proteasome inhibition as a (potential) virulence strategy has only recently become apparent in a small but interesting group of plant and animal pathogens. This group will without doubt grow in the future, but it remains to be seen how prevalent proteasome inhibition as a virulence strategy of pathogens is. In view of the involvement of the UPS in regulatory pathways controlling almost all aspects of plant life, proteasome inhibition appears, due to the expected pleiotropic consequences, rather like a drastic sledgehammer method to suppress plant immunity.This contrasts with the often exquisitely precise interference with specific host defense signal transduction components that characterizes the action of many T3Es. However, this view may be exaggerated. Tight regulation of inhibitor production [55] , the inhibitor-triggered de novo synthesis of proteasomes as suggested by transcriptome analyses [69] , as well as spacial restriction of the inhibitor to the neighborhood of infection sites due to cellular uptake and proteasome binding may render proteasome inhibition much less pleiotropic than suggested by the known involvement of the UPS in a plethora of cellular processes. This is evidenced by the fact that SylA is not a deadly toxin that kills cells, but helps biotrophic bacteria to suppress the SAdependent defense pathway and to spread from wound infection sites [52, 53] . Further research will be required to determine the contribution of syrbactins and other proteasome inhibitors to the virulence of pathogens. [56, 57] . The first NRPS module of SylD is thought to activate lysine (Lys), which is desaturated to 3,4-dehydrolysine by the sylB gene product [43] . The second SylD NRPS module is thought to activate valine, which, after condensation/decarboxylation to a malonate residue activated by the type I PKS module of SylD, results in a β-keto-thioester whose β-keto group is twofold reduced by the KR and DH domains, thus resulting in the 5-methyl-4-amino-2-hexenoic acid (MAH) moiety. Finally, lactam bond formation between the terminal carboxyl group and the ε-amino group of the 3,4-dehydrolysine moiety catalyzed by the TE domain of the PKS module leads to cyclization and release of the final product [58] .
Genes, domains/proteins and the molecular entities they act upon are given in the same color shades. Adapted with permission from [54] . Figure 2 . The glbA gene encodes a LysR-type transcriptional regulator [64] , whereas glbE encodes an MbtH-like chaperone [65] . The function of the glbB, glbG, and glbH genes is currently unknown. (B) GlbA biosynthesis model. The GlbF NRPS starter module activates threonine (Thr) and N-acylates it with a coenzyme A-activated fatty acid [65] . The first NRPS module of GlbC is thought to activate lysine (Lys), which is oxidized to 4-hydroxylysine by an as yet unknown enzyme.
The second NRPS module is thought to activate alanine (Ala), which, after condensation/decarboxylation to a malonate residue activated by the type I PKS module of GlbC, results in a diketide that is twofold reduced by the KR and DH domains, thus resulting in the 4-amino-2-pentenoic acid (APA) moiety. Macrolactam ring formation and release is catalyzed by the TE domain. Genes, domains/proteins and the molecular entities they act upon are given in identical color shades. Adapted with permission from [64] . 
